SGK
Steigerwald Gordon & Koch Portfolio holdings
AUM
$948M
This Quarter Return
+7.4%
1 Year Return
+17.35%
3 Year Return
+62.97%
5 Year Return
+126.95%
10 Year Return
+248.69%
AUM
$245M
AUM Growth
+$245M
(+8.5%)
Cap. Flow
+$5.01M
Cap. Flow
% of AUM
2.04%
Top 10 Holdings %
Top 10 Hldgs %
31.71%
Holding
62
New
6
Increased
22
Reduced
28
Closed
1
Top Buys
| 1 |
T Rowe Price
TROW
|
$5.91M |
| 2 |
BorgWarner
BWA
|
$388K |
| 3 |
Kinder Morgan
KMI
|
$375K |
| 4 |
Northrop Grumman
NOC
|
$309K |
| 5 |
Elevance Health
ELV
|
$231K |
Top Sells
| 1 |
Microsoft
MSFT
|
$636K |
| 2 |
CACI
CACI
|
$634K |
| 3 |
iShares International Select Dividend ETF
IDV
|
$631K |
| 4 |
iShares TIPS Bond ETF
TIP
|
$396K |
| 5 |
Accenture
ACN
|
$257K |
Sector Composition
| 1 | Technology | 26.16% |
| 2 | Healthcare | 19.49% |
| 3 | Communication Services | 10.67% |
| 4 | Consumer Staples | 8.57% |
| 5 | Energy | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Smith & Wesson
SWBI
$359M
| $275K | 0.11% |
12,500
| – | – |
|
52
Cisco
CSCO
$267B
| $255K | 0.1% |
9,389
+115
| +1% | +$3.12K |
|
53
Goldman Sachs
GS
$221B
| $250K | 0.1% |
1,387
| – | – |
|
54
Ligand Pharmaceuticals
LGND
$3.22B
| $217K | 0.09% |
+1,998
| New | +$217K |
|
55
Norfolk Southern
NSC
$62.4B
| $215K | 0.09% |
2,546
-299
| -11% | -$25.2K |
|
56
Pfizer
PFE
$141B
| $214K | 0.09% |
6,634
+100
| +2% | +$3.23K |
|
57
JPMorgan Chase
JPM
$821B
| $209K | 0.09% |
+3,160
| New | +$209K |
|
58
Target
TGT
$41.8B
| $207K | 0.08% |
2,856
+1
| +0% | +$72 |
|
59
Bristol-Myers Squibb
BMY
$96.9B
| $203K | 0.08% |
+2,945
| New | +$203K |
|
60
Opko Health
OPK
$1.1B
| $166K | 0.07% |
16,500
| – | – |
|
61
HP
HPQ
$26.8B
| $122K | 0.05% |
+10,282
| New | +$122K |
|
62
Walmart
WMT
$784B
| – | – |
-3,150
| Closed | -$204K |
|